XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Targus
Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Targus
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock, shares outstanding (in shares)       28,523,764          
Beginning balance (in shares) at Dec. 31, 2022     4,545            
Beginning balance at Dec. 31, 2022 $ 505,893   $ 0 $ 3 $ 494,201   $ (45,220) $ (2,470) $ 59,379
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Preferred stock issued (in shares)     18            
Preferred stock issued 467       467        
Vesting of restricted stock and other, net of shares withheld for employer taxes (in shares)       1,012,751          
Vesting of restricted stock and other, net of shares withheld for employer taxes (4,819)       (4,819)        
Common stock repurchased and retired (in shares)       (1,452,831)          
Common stock repurchased and retired (53,803)       (53,803)        
Shares issued for the acquisition of a business (in shares)       51,952          
Shares issued for the acquisition of a business 2,111       2,111        
Remeasurement of Lingo redeemable minority interest   $ (6,483)       $ (6,483)      
Share based payments 13,678       13,678        
Dividends on common stock (31,291)           (31,291)    
Dividends on preferred stock (2,012)           (2,012)    
Net loss 16,706           17,155   (449)
Distributions to noncontrolling interests (720)               (720)
Contributions from noncontrolling interests 431               431
Remeasurement of B. Riley Principal 250 Merger Corporations subsidiary temporary equity (1,198)           (1,198)    
Acquisition of noncontrolling interests 538               538
Other comprehensive loss 866             866  
Ending balance (in shares) at Mar. 31, 2023     4,563            
Ending balance at Mar. 31, 2023 $ 440,364   $ 0 $ 3 445,352   (62,566) (1,604) 59,179
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock, shares outstanding (in shares)       28,135,636          
Common stock, shares outstanding (in shares) 29,937,067     29,937,067          
Beginning balance (in shares) at Dec. 31, 2023     4,563            
Beginning balance at Dec. 31, 2023 $ 359,566   $ 0 $ 3 572,170   (281,285) 229 68,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Vesting of restricted stock and other, net of shares withheld for employer taxes (in shares)       158,236          
Vesting of restricted stock and other, net of shares withheld for employer taxes (1,170)       (1,170)        
Share based payments 8,611       8,611        
Share based payments in equity of subsidiary 36       36        
Dividends on common stock (15,093)           (15,093)    
Dividends on preferred stock (2,015)           (2,015)    
Net loss (47,954)           (49,165)   1,211
Distributions to noncontrolling interests (954)               (954)
Contributions from noncontrolling interests 2,502               2,502
Other comprehensive loss (3,872)             (3,872)  
Ending balance (in shares) at Mar. 31, 2024     4,563            
Ending balance at Mar. 31, 2024 $ 299,657   $ 0 $ 3 $ 579,647   $ (347,558) $ (3,643) $ 71,208
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock, shares outstanding (in shares) 30,095,303     30,095,303